GlassScriptPhysician profile
Jerome Dwyer
NPI 1477515047
$14,201.68
in general payments reported to CMS, 2019-2025
25 companies · $960 in 2025
The $960 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,495 · 2020: $471 · 2021: $1,534 · 2022: $5,072 · 2023: $1,994 · 2024: $1,676 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,811 · Travel and Lodging: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,810.50 |
| Travel and Lodging | $819.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $8,283.25 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Novartis Pharmaceuticals Corporation | $1,175.40 | 2020-2025 | |
| Boston Scientific Corporation | $840.16 | 2023-2024 | Watchman Access System, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $618.06 | 2019-2024 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $428.11 | 2019-2024 | Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $384.41 | 2021-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.38 | 2019-2024 | Jardiance |
| Esperion Therapeutics, INC. | $346.32 | 2020-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $281.65 | 2022-2023 | Verquvo |
| Amgen INC. | $269.30 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $237.72 | 2019-2022 | |
| Cvrx, INC. | $208.80 | 2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $162.87 | 2019-2023 | |
| Pfizer INC. | $131.35 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $120.98 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $100.12 | 2024 | Cobalt Dr Mri Surescan |
| Kestra Medical Technology Services, INC. | $71.33 | 2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $28.95 | 2019 | |
| Edwards Lifesciences Corporation | $25.47 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $25.32 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Baxter Healthcare | $22.69 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Heartflow, INC. | $22.30 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $19.70 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $18.40 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $17.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Dwyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.